Investing.com - Boston Scientific (NYSE:BSX) reported third quarter earnings that missed analyst's expectations on Wednesday and revenue that fell short of forecasts.
The firm reported earnings per share of $0.31 on revenue of $2.39B. Analysts polled by Investing.com expected EPS of $0.34 on revenue of $2.4B. That compared to EPS of $0.31 on revenue of $2.22B in the same period a year earlier. The company had reported EPS of $0.41 on revenue of $2.49B in the previous quarter.
For the year, Boston Scientific shares are up 44.47%, outperforming the S&P 500 which is up 2.12% year to date.
Boston Scientific follows other major Healthcare sector earnings this month
On October 16, J&J (NYSE:JNJ) reported third quarter EPS of $2.05 on revenue of $20.35B, compared to forecasts of EPS of $2.03 on revenue of $20.04B.
Novartis ADR earnings beat analyst's expectations on October 18, with third quarter EPS of $1.32 on revenue of $12.78B. Investing.com analysts expected EPS of $1.31 on revenue of $12.98B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar